The headline numbers for ClearPoint Neuro (CLPT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -31.03% and -16.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Mettler-Toledo (MTD) delivered earnings and revenue surprises of +6.31% and -0.46%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OPKO Health (OPK) delivered earnings and revenue surprises of +87.50% and +24.68%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

DarioHealth (DRIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.